These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 874026)

  • 1. Comparison of non-biospecific effects in immunoaffinity chromatography using cyanogen bromide and bifunctional oxirane as immobilising agents.
    Murphy RF; Conlon JM; Imam A; Kelly GJ
    J Chromatogr; 1977 May; 135(2):427-33. PubMed ID: 874026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoaffinity chromatography.
    Springer TA
    Curr Protoc Protein Sci; 2001 May; Chapter 9():Unit 9.5. PubMed ID: 18429214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling antibody to cyanogen bromide-activated sepharose.
    Kavran JM; Leahy DJ
    Methods Enzymol; 2014; 541():27-34. PubMed ID: 24674060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoidance of strongly chaotropic eluents for immunoaffinity chromatography by chemical modification of immobilized ligand.
    Murphy RF; Imam A; Hughes AE; McGucken MJ; Buchanan KD; Conlon JM; Elmore DT
    Biochim Biophys Acta; 1976 Jan; 420(1):87-96. PubMed ID: 2298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CNBr, FMP and hydrazide resins for immunoaffinity purification of factor IX.
    Highsmith F; Regan T; Clark D; Drohan W; Tharakan J
    Biotechniques; 1992 Mar; 12(3):418-23. PubMed ID: 1571154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of poliovirus type 1 from a protein mixture using an immunoaffinity chromatography column.
    Cameron-Smith R; Harbour C
    Biomed Chromatogr; 2001 Nov; 15(7):471-83. PubMed ID: 11746244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoaffinity chromatography.
    Jack GW; Beer DJ
    Methods Mol Biol; 1996; 59():187-96. PubMed ID: 8798199
    [No Abstract]   [Full Text] [Related]  

  • 8. Biospecific fractionation matrices for sequence specific endonucleases.
    George J; Chirikjian JG
    Nucleic Acids Res; 1978 Jul; 5(7):2223-32. PubMed ID: 673852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compared stability of Sepharose-based immunoadsorbents prepared by various activation methods.
    Ubrich N; Hubert P; Regnault V; Dellacherie E; Rivat C
    J Chromatogr; 1992 Dec; 584(1):17-22. PubMed ID: 1487514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen purification by monoclonal antibody immunoaffinity chromatography.
    Brassfield AL
    Methods Mol Biol; 1995; 45():195-203. PubMed ID: 7550683
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of 1,1'-carbonyldiimidazole-activated matrices for the purification of proteins. III. The use of 1,1'-carbonyldiimidazole-activated agaroses in the biospecific affinity chromatographic isolation of serum antibodies.
    Hearn MT; Harris EL; Bethell GS; Hancock WS; Ayers JA
    J Chromatogr; 1981 Nov; 218():509-18. PubMed ID: 7320121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical studies of the non-specific interactions of cyanogen bromide-activated macroporous agarose-based immunoadsorbents.
    Kennedy JF; Barnes JA
    J Chromatogr; 1983 Dec; 281():83-93. PubMed ID: 6668343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and other factors affecting biospecific desorption in chromatography of proteins. A study by computer simulation.
    Yon RJ
    Biochem J; 1980 Jan; 185(1):211-6. PubMed ID: 7378048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity chromatography of lipase with hydrophobic ligands coupled to cyanogen bromide-activated agarose.
    Kosugi Y; Suzuki H
    J Lipid Res; 1976 Jul; 17(4):307-13. PubMed ID: 7632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of human ovarian tumor-associated antigen and demonstration of circulating tumor antigen in patients with advanced ovarian malignancy.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1977 Apr; 127(7):705-10. PubMed ID: 66873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform.
    Hsieh SK; Yu YJ; Tang NY; Lin JR; Jinn TR
    Protein Pept Lett; 2017; 24(11):1021-1029. PubMed ID: 28741464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an SDS-gel-separated protein band as a ligand for affinity chromatography: procedure and application to the purification of domain-specific antibodies against alpha-actinin.
    Yoshihara Y; Kuroda M
    J Biochem; 1995 Feb; 117(2):443-6. PubMed ID: 7608136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A device for CNBr activation of agarose gels.
    Korpela T; Kurkijärvi K
    Anal Biochem; 1980 May; 104(1):150-2. PubMed ID: 7386875
    [No Abstract]   [Full Text] [Related]  

  • 19. Affinity purification methods. Improved procedures for cyanogen bromide reaction on agarose.
    Nishikawa AH; Bailon P
    Anal Biochem; 1975 Mar; 64(1):268-75. PubMed ID: 1137087
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimisation of the coupled monoclonal antibody density for recombinant hepatitis B virus surface antigen immunopurification.
    Hernández R; Plana L; Gómez L; Expósito N; Valdés J; Páez R; Martínez E; Beldarraín A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):1-6. PubMed ID: 15664326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.